SBIR/STTR Research Award
SBIR Phase I: Development of a Novel Diagnostic Test for Pulmonary Embolism Based on Artificial Intelligence and Spectral Analysis of Blood
Award amount
$209,881Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- Biocogniv Inc.
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-08-31
- UEI
- DR19LY8GPNW1
- Solicitation number
- Not reported
- Topic code
- AI
Research abstract
The broader impact of this Small Business Innovation Research (SBIR) Phase I project will result from the development of a fast, non-invasive, and highly accurate test to diagnose pulmonary embolism in the emergency department. In the United States, pulmo
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
2 SBIR/STTR records share this UEI (2020). Reported award amounts total $509,630. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, National Science Foundation